ID 405119893 · FY 2018–2021 · 4 years
Subsidiary of იბერი + (100.0%)
Iberipharma + (იბერიფარმა +, iberipharma.ge) — a Georgian pharmacy chain of around 29 stores nationwide (Tbilisi, Batumi, Kutaisi, Poti, Gurjaani and others), also acting as exclusive distributor of a few medicines (e.g. Reamberin, Cycloferon) under GDP-standard warehousing. Primarily a retail pharmacy chain. NOTE: no financial filings in our data after FY2021 — current operating status unconfirmed (possibly closed, restructured, or simply no longer filing).
curated 2026-06-25
| Line item | 2018 | 2019 | 2020 | 2021 | CAGR |
|---|---|---|---|---|---|
| Total Revenue | 5,169 | 6,072 | 7,087 | 7,246 | +11.9% |
| Total COGS | -4,458 | -5,086 | -5,883 | -6,125 | +11.2% |
| Gross Profit | 711 | 986 | 1,204 | 1,121 | +16.4% |
| Gross Margin | 13.8% | 16.2% | 17.0% | 15.5% | |
| Total Operating Expenses | -960 | -1,086 | -1,356 | -1,899 | +25.5% |
| EBITDA | -248 | -100 | -152 | -778 | +46.3% |
| EBITDA Margin | -4.8% | -1.6% | -2.1% | -10.7% | |
| Total D&A | -21 | -24 | -26 | -34 | +17.4% |
| EBIT / Operating Income | -270 | -124 | -178 | -812 | +44.4% |
| Profit Before Tax | -270 | -124 | -178 | -812 | +44.4% |
| Total Income Tax | 0 | 0 | 0 | 0 | |
| Net Profit / (Loss) | -248 | -100 | -152 | -778 | +46.3% |
| Net Margin | -4.8% | -1.6% | -2.1% | -10.7% |
Ownership & directors from companyinfo.ge (public corporate registry).